New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
Go back to New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026| BARNES GROUP, Inc. (NYSE: B) | Delayed: 43.69 +1.14 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.55 | 52 Week High | $44.27 | |||
| Open | $43.67 | 52 Week Low | $30.07 | |||
| Day High | $44.02 | P/E | 33.35 | |||
| Day Low | $43.22 | EPS | $1.31 | |||
| Volume | 6,885,462 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 8.09 +0.34 (4.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.75 | 52 Week High | $8.73 | |||
| Open | $7.85 | 52 Week Low | $2.86 | |||
| Day High | $8.36 | P/E | N/A | |||
| Day Low | $7.70 | EPS | $-3.82 | |||
| Volume | 940,132 | |||||
